Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma. Guo H, Tan YQ, Huang X, Zhang S, et al. Cancer Lett 2023;579:216443.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Guo H, Tan YQ, Huang X, Zhang S, et al. Small molecule inhibition of TFF3 overcomes tamoxifen resistance and enhances taxane efficacy in ER+ mammary carcinoma. Cancer Lett 2023;579:216443.
PMID: 37858772